Workflow
Ascendis Pharma's therapy for children with dwarfism
icon
搜索文档
US FDA extends review of Ascendis Pharma's therapy for children with dwarfism
Reuters· 2025-11-25 23:21
监管审批动态 - 美国食品药品监督管理局延长对Ascendis Pharma针对一种导致侏儒症的罕见遗传病儿童疗法的审查 [1]